Report cover image

ISSUE 5 of 6 - In Vitro Diagnostics Business Outlook: Focus on Continuous Glucose Monitoring (CGM)

Published Oct 01, 2025
Length 49 Pages
SKU # KLI20501494

Description

The in vitro diagnostics (IVD) sector stands as a cornerstone of modern healthcare, empowering clinicians with the tools to detect diseases, monitor health conditions, and guide precise treatment decisions.

As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well as ongoing threats from infectious diseases like COVID-19 and emerging variants, the demand for innovative diagnostic solutions has never been greater.

In Vitro Diagnostics Business Outlook is a bimonthly publication, delivering six issues annually, each dedicated to a different segment of the IVD industry. It provides exclusive insights and data, including:
  • Market Data and Forecasts: Detailed growth rates, market size, and market share to identify new opportunities.
  • Comprehensive Market View: Coverage of test categories and company profiles.
  • M&A Activities: Updates on mergers, acquisitions, partnerships, and collaborations.
  • Industry & Region Watch: Tailored strategies based on regional and industry-specific trends.
  • News Analysis: In-depth reporting on significant news and events, including exclusive information not readily available elsewhere.
Please Note: Single user allows for up to 3 users for this report.

Table of Contents

49 Pages
MARKET ANALYSIS: CONTINUOUS GLUCOSE MONITORING
OVERVIEW OF CONTINUOUS GLUCOSE MONITORING
MARKET OUTLOOK: CONTINUOUS GLUCOSE MONITORING
OVERVIEW OF CONTINUOUS GLUCOSE MONITORING
Table: Glucose Testing Market, Sales by Broad Category, 2025 and 2030 ($ million) [Glucose Continuous, Glucose OTC, Glucose Professional]
Figure: Glucose Testing Market, Continuous Glucose Monitor Distribution of Total Sales, 2025 and 2030 [Glucose Continuous and Remaining Glucose Testing Market]
Figure: Glucose Testing Market, Continuous Glucose Monitor, Estimated Distribution of Total Sales by Modality [rtCGM, isCGM, implantable CGM], 2025 (%)
REGIONAL MARKET
Figure: Global Continuous Glucose Testing Market, Estimated Market Value by Region, 2025 ($ million) [Europe, Japan, United States, RoW]
COMPANY BRIEFS
Abbott Diagnostics
Medtronic
Dexcom
Senseonics
EXECUTIVE NEWS BRIEFING
RAPIDEMIC SECURES €2.3 MILLION GRANT
STRATIFAI SECURES €12.5 MILLION FOR PRECISION ONCOLOGY
PREDICTA BIOSCIENCES RAISES $23.4 MILLION IN SERIES A FUNDING
PREDICTA BIOSCIENCES WELCOMES NEW CEO
OWLSTONE MEDICAL SCORES $49.1 MILLION
FINANCIAL HIGHLIGHTS: FULGENT GENETICS, THERMO FISHER SCIENTIFIC
FULGENT GENETICS POSTS STRONG PERFORMANCE IN CORE REVENUE
Figure: Fulgent Genetics’ Financial Results by Q1 2024 Through Q2 2025 ($ million)
Figure: Fulgent Genetics Distribution of Revenues by Payor, H1 2025
Figure: Fulgent Genetics Revenue Performance by Geographic Region, H1 2025
THERMO FISHER MAINTAINS STEADY PERFORMANCE IN H1 2025
Table: Thermo Fisher Scientific Sales by Division, 6M 2024 and 6M 2025 ($ million)
Figure: Thermo Fisher Scientific, Sales by Division, 6M 2024 and 6M 2025 ($ million)
Table: Thermo Fisher Scientific 2025 Highlights by Quarter, Q1 2025 vs. Q2 2025
DIAGNOSTIC MARKET MERGERS, ACQUISITIONS, AND PARTNERSHIP DEALS
PARTNERSHIPS AND COLLABORATIONS
Mergers and Acquisitions
Table: Recent Diagnostic Market Mergers, Acquisitions, and Partnership Deals, Dec. 2024-Oct. 2025
INDUSTRY WATCH
INDUSTRY WATCH COVID-19/FLU UPDATE
REGION WATCH
BELGIUM
Figure: Belgium: Overall Share of Health Spending (Government/Compulsory Schemes, Out-of-Pocket [OOP], Voluntary Health Insurance [VHI]), 2023
Figure: Belgium: Market Distribution of Broad IVD Segments, 2025 (%)
BROAD-BASED COMPANY ANNOUNCEMENTS
GUARDANT HEALTH SECURES FDA NOD FOR CDX
CLEARNOTE HEALTH RECEIVES UKCA APPROVAL FOR TWO EARLY DETECTION CANCER TESTS
XPEDITE DX LAUNCHES ONE-STEP VIRAL DNA/RNA EXTRACTION KIT
NEUROKAIRE LAUNCHES UNIQUE TEST FOR MDD
MIRXES GAINS NMPA APPROVAL
CND LIFE SCIENCES SCORES FDA BREAKTHROUGH DEVICE DESIGNATION
HOLOGIC GAINS FDA AND CE MARK FOR MOLECULAR TESTS
J&J INTENDS TO SPIN OFF ORTHOPEDIC BUSINESS
ROCHE RECEIVES GO-AHEAD FROM FDA

Search Inside Report

How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.